COGENT BIOSCIENCES INC's ticker is COGT and the CUSIP is 19240Q201. A total of 74 filers reported holding COGENT BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,350,877 | -13.5% | 651,372 | +5.1% | 1.93% | -15.2% |
| Q2 2023 | $7,340,800 | +17.4% | 620,000 | +7.0% | 2.27% | -12.0% |
| Q1 2023 | $6,250,259 | +202.1% | 579,264 | +223.6% | 2.58% | +335.8% |
| Q4 2022 | $2,069,240 | -77.1% | 179,000 | -70.5% | 0.59% | -80.7% |
| Q3 2022 | $9,051,000 | +22.2% | 606,608 | -26.1% | 3.06% | +34.3% |
| Q2 2022 | $7,405,000 | +72.3% | 820,954 | +43.1% | 2.28% | +28.2% |
| Q1 2022 | $4,297,000 | -41.1% | 573,699 | -32.6% | 1.78% | -39.9% |
| Q4 2021 | $7,301,000 | +28.1% | 850,935 | +25.5% | 2.96% | -8.2% |
| Q3 2021 | $5,701,000 | +254.5% | 677,900 | +242.0% | 3.22% | +349.5% |
| Q2 2021 | $1,608,000 | +52.6% | 198,245 | +65.2% | 0.72% | +24.7% |
| Q1 2021 | $1,054,000 | -60.1% | 120,000 | -49.0% | 0.58% | -62.5% |
| Q4 2020 | $2,640,000 | – | 235,066 | – | 1.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 1,558,975 | $17,507,000 | 6.26% |
| COMMODORE CAPITAL LP | 760,025 | $8,535,000 | 4.64% |
| Ally Bridge Group (NY) LLC | 1,622,591 | $18,222,000 | 3.12% |
| Ghost Tree Capital, LLC | 1,100,000 | $12,353,000 | 2.75% |
| Logos Global Management LP | 1,920,500 | $21,567,000 | 1.85% |
| Altium Capital Management LP | 432,563 | $4,858,000 | 1.81% |
| VR Adviser, LLC | 1,088,817 | $12,227,000 | 1.80% |
| Atlas Venture Associates IX, LLC | 916,196 | $10,289,000 | 1.63% |
| Atlas Venture Associates XI, LLC | 916,196 | $10,289,000 | 1.63% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 235,066 | $2,640,000 | 1.53% |